Outlook Therapeutics
OTLK
#8491
Rank
NZ$0.22 B
Marketcap
$9.42
Share price
-7.55%
Change (1 day)
-37.05%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -NZ$0.16 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$88.02 Million, an increase over its 2022 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.16 Billion79.49%
2023 -NZ$88.02 Million-26.7%
2022 -NZ$0.13 Billion32.13%
2021 -NZ$90.87 Million46.21%
2020 -NZ$62.16 Million-18.82%
2019 -NZ$76.57 Million16.62%
2018 -NZ$65.65 Million57.88%
2017 -NZ$41.59 Million-56.17%
2016 -NZ$94.87 Million-9.26%
2015 -NZ$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.2 Billion 21.71% Jersey
-NZ$0.47 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$23.91 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.13 Billion-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK